Fierce Pharma

AUGUST 27, 2024

Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label co | Eli Lilly is offering its popular weight-loss drug Zepbound directly to consumers at a discount through its own online pharmacy. The company hopes the move could expand access while addressing other issues such as high prices and off-label cosmetic usage.

Patients 313

Patients 313

PharmaVoice

AUGUST 27, 2024

While AI, machine learning and large language models can distill huge amounts of information, they sometimes make mistakes. New technologies could rebuild that trust.

106

106

Fierce Pharma

AUGUST 27, 2024

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. | In June, when the Supreme Court voted 6-3 to overturn the Chevron doctrine, it brought significant impact for the healthcare industry and federal regulators like the FDA and the Centers for Medicare & Medicaid Services.

Biopharma 299

Biopharma FDA Pharma Healthcare 299

MedCity News

AUGUST 27, 2024

No revolutionary naval vessels, fighter planes, or weapon systems were involved. Rather, this one was about staffing military healthcare facilities. Make no mistake, though: It’s also revolutionary. The post A Revolution in Military Medical Staffing is Afoot and Private Sector Firms are Playing a Big Part appeared first on MedCity News.

Medical 105

Medical Healthcare Healthcare 105

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

AUGUST 27, 2024

Four months after emerging from bankruptcy, Endo is in transition again with the sudden departure of CEO Blaise Coleman. | Four months after emerging from bankruptcy, Endo Pharmaceuticals is in transition again with the sudden departure of CEO Blaise Coleman. Without providing a reason, the Dublin-based company revealed Coleman’s eventful four-year tenure will end Thursday.

Pharmaceutical 130

Pharmaceutical 130

MedCity News

AUGUST 27, 2024

Through community engagement, the root causes of healthcare disparities can be addressed, and the health and resiliency of individuals can be dramatically improved. The post Increasing Health Equity Through Accessibility and Education appeared first on MedCity News.

Education 102

Education Healthcare Healthcare Patients 102

Pharmaceutical Technology

AUGUST 27, 2024

Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox clade Ib case.

111

111

pharmaphorum

AUGUST 27, 2024

Roche's PiaSky is the first therapy for rare blood disorder PNH that can be given by monthly subcutaneous injection in the EU.

107

107

MedCity News

AUGUST 27, 2024

Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is “inconsistent” with the 340B statute, according to HRSA. The post J&J’s Change to 340B Discounts is “Inconsistent” with Statute, HRSA Says appeared first on MedCity News.

Medical 80

Medical Biopharma 80

pharmaphorum

AUGUST 27, 2024

Regeneron's Ordspono (odronextamab) for non-Hodgin lymphoma (NHL) is cleared in EU five months after being turned down by the FDA

FDA 102

FDA 102

Advertisement

MedCity News

AUGUST 27, 2024

OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNY’s life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social determinants of health.

Networking 74

Networking Medical Patients Biopharma 74

pharmaphorum

AUGUST 27, 2024

J&J's Balversa has been approved in the EU for advanced bladder cancer with FGFR3 genetic alterations after one line of prior therapy

98

98

PharmaTimes

AUGUST 27, 2024

Over 135,000 people have signed a petition to prioritise a national screening programme

106

106

Pharmaceutical Commerce

AUGUST 27, 2024

The agency provides an update surrounding the Act’s implementation efforts.

FDA 110

FDA 110

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

pharmaphorum

AUGUST 27, 2024

US biotech MBX Biosciences, files for an IPO, seeking around $100 million to take a hypoparathyroidism candidate into phase 3

89

89

Pharmaceutical Technology

AUGUST 27, 2024

Eli Lilly and Novo Nordisk have announced that the supply of their GLP-1 weight loss drugs has improved with increased availability of Zepbound, Mounjaro, Wegovy, and Trulicity.

Sales 59

Sales 59

Pharmaceutical Commerce

AUGUST 27, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma 105

PharmaTech

AUGUST 27, 2024

PiaSky (crovalimab) has previously been approved in countries such as the United States and Japan for monthly, subcutaneous use that may be self-administered with adequate training.

Training 52

Training 52

Advertisement

Distribution

Referral MD

AUGUST 27, 2024

Expanding your medical practice is an exciting venture, but it comes with its own challenges—especially regarding real estate. In the latest episode of our podcast , we dive deep into essential real estate tips tailored for growing medical practices. Whether you’re looking to lease new space, select the perfect location, or optimize your current practice layout, these expert insights will guide you through the process.

Medical 52

Medical Patients Management Education 52

PharmExec

AUGUST 27, 2024

Achieving better outcomes for patients and advancing the fields of nuclear medicine and oncology are not just about adopting new technologies, but also about embracing a profound change in how care is delivered.

Medicine 52

Medicine Patients 52

PharmaTimes

AUGUST 27, 2024

The spread of multiple bacteria could be tracked simultaneously through sequencing method

74

74

PharmExec

AUGUST 27, 2024

Shorespan-007 is expected to enroll approximately 300 patients with essential thrombocythemia and will compare bomedemstat to hydroxyurea, the current standard of care.

Patients 52

Patients 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

AUGUST 27, 2024

The US FDA has granted fast track designation for BeiGene’s BGB-16673 to treat lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL).

FDA 52

FDA 52

PharmExec

AUGUST 27, 2024

Expanded indication makes Omnipod the first automated insulin delivery system to be approved for the management of both type 1 and type 2 diabetes.

FDA 52

FDA Management 52

Pharmaceutical Technology

AUGUST 27, 2024

SIFI has received the European Commission approval for AKANTIOR to treat acanthamoeba keratitis (AK), a rare and severe corneal infection.

52

52

PharmExec

AUGUST 27, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Pharmaceutical Technology

AUGUST 27, 2024

The EC has granted approval to Roche’s PiaSky for the treatment of paroxysmal nocturnal haemoglobinuria in adult and adolescent patients.

Patients 52

Patients 52

PharmExec

AUGUST 27, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Pharmaceutical Technology

AUGUST 27, 2024

UCB has entered a divestment agreement in China to sell its mature neurology and allergy business to CBC Group and Mubadala for $680m.

52

52

Pharmacy Times

AUGUST 27, 2024

With diagnostic tools, oncology pharmacists and other health care providers can help to identify treatments that have the best probability of working for a specific patient.

FDA 49

FDA Patients 49

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety